Fisher Andrew

General CounselVerona Pharma plc (VRNA) · full profile →Form 4 · filed Oct 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
3 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Option exercise(M)932K932K
Oct 7, 2025Disposed to issuer(D)418K0
Oct 7, 2025Disposed to issuer(D)932K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 7, 2025Option exercise(M)619K0
Oct 7, 2025Disposed to issuer(D)2.2M0
Oct 7, 2025Grant(A)619K619K
Oct 7, 2025Option exercise(M)167K0
Oct 7, 2025Option exercise(M)146K0

Transaction Codes

M
Option exercise / conversion
D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-097967) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.